EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

A Missense Mutation c.1132G > A in Fumarate Hydratase (FH) Leads to Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Syndrome and Insights into Clinical Management in Uterine Leiomyomata

Yue Shi iD, Yan Xu, Chao Wang, Yiqing Chen, Xiaojun Ren, Yu Kang, Chao Wang

Genes · 2023

DOI: 10.3390/genes14030744 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, 2023. Verfasst von Yue Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China. Hauptthemen laut MEDLINE: Kidney Neoplasms, Uterine Neoplasms, Leiomyomatosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Clinical Research Plan of SHDC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

HLRCC syndrome is a hereditary cancer predisposition syndrome caused by heterozygous germline pathogenic variant of the fumarate hydratase (FH) gene and characterized by cutaneous leiomyomas (CL), uterine leiomyomas (UL), and renal cell carcinoma (RCC). Loss of function variant of FH gene inactivates the Kreb’s cycle enzyme activity and predisposes individuals with such variant to the development of HLRCC.

Methods

Next-generation sequencing (NGS) and Sanger confirmation were given to family members accessible. Following that, a functional study in vitro was performed to further confirm the pathogenicity of the variant. FH-Wild type (FH-WT) and FH-mutant (FH-MUT) (E378K) plasmid were constructed and transfected into 293T and uterine leiomyoma cell lines, respectively. Proliferation assessment was executed to show how this mutation affects the growth of uterine leiomyoma. qPCR and Western blotting were performed to investigate the change of transcription and translation of FH with mutation (E378K), and FH enzyme assay activity were tested in 293T cells with mutation and wild-type plasmids.

Results

Here, we presented two families with the same missense variant (c.1132G > A) that has not been reported as a germline mutation in hereditary uterine leiomyomas before and classified as VUS in gene databases. Our in vitro experiments supported the pathogenicity of this missense variant, especially in uterine leiomyomata.

Conclusions

According to the American College of Medical Genetics (ACMG) guideline, the E378K variant was classified as likely pathogenic (with evidence PS4_support, PS3_support, PM2_support, PP1, PP3 and PP4 evidence). Further insights into clinical management in uterine leiomyomata were discussed and should be practiced in gynecological clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsUterine NeoplasmsLeiomyomatosisSkin NeoplasmsNeoplastic Syndromes, HereditaryMutation, MissenseFumarate HydrataseSyndromeFemaleHumans

Stichwörter der Autor:innen

clinical management in hereditary gynecological diseasefumarate hydratase (FH) genehereditary leiomyomatosis and renal cell cancer syndrome (HLRCC)in vitro functional study

Substanzen

Fumarate Hydratase

Autor:innen und Institutionen

  • Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China.
  • Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, China.

ORCID-Profile: Yue Shi

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai
  • Clinical Research Plan of SHDC
  • Shanghai Science and technology committee medical guidance program
  • Shanghai “Rising Stars of Medical Talent” Youth Development Program-Outstanding Youth Medical Talents

Zitieren

APA

Shi, Y., Xu, Y., Wang, C., Chen, Y., Ren, X., Kang, Y., & Wang, C. (2023). A Missense Mutation c.1132G > A in Fumarate Hydratase (FH) Leads to Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Syndrome and Insights into Clinical Management in Uterine Leiomyomata. Genes. https://doi.org/10.3390/genes14030744

Vancouver

Shi Y, Xu Y, Wang C, Chen Y, Ren X, Kang Y, et al. A Missense Mutation c.1132G > A in Fumarate Hydratase (FH) Leads to Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Syndrome and Insights into Clinical Management in Uterine Leiomyomata. Genes. 2023. doi:10.3390/genes14030744

BibTeX
@article{Shi2023,
  author = {Shi, Yue and Xu, Yan and Wang, Chao and Chen, Yiqing and Ren, Xiaojun and Kang, Yu and Wang, Chao},
  title = {A Missense Mutation c.1132G > A in Fumarate Hydratase (FH) Leads to Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Syndrome and Insights into Clinical Management in Uterine Leiomyomata},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14030744}
}
Kostenlos starten →